Enochian Biosciences Inc (63)
Browse by Contract Category
Contracts
-
Form of Subscription Agreement
(Filed With SEC on April 3, 2023)
-
Form of Warrant
(Filed With SEC on April 3, 2023)
-
Amendment No.2 to Promissory Note, dated May 17, 2022
(Filed With SEC on February 27, 2023)
-
Security Agreement
(Filed With SEC on February 23, 2023)
-
Amendment to Promissory Note
(Filed With SEC on February 23, 2023)
-
Form of Amended and Restated Senior Secured Convertible Promissory Note
(Filed With SEC on February 23, 2023)
-
Amendment to Employment Agreement between Mark Dybul, M.D. and Enochian Biosciences Inc., dated December 12, 2022
(Filed With SEC on December 16, 2022)
-
Employment Agreement between Enochian Biosciences, Inc. and Dr. Mark Dybul, dated August 11, 2021
(Filed With SEC on August 16, 2021)
-
License Agreement
(Filed With SEC on April 22, 2021)
-
Form of Subscription Agreement
(Filed With SEC on March 24, 2021)
-
Description of Securities
(Filed With SEC on September 23, 2020)
-
Purchase Agreement, dated July 8, 2020, by and between the Company and Lincoln Park Capital Fund, LLC
(Filed With SEC on July 14, 2020)
-
Registration Rights Agreement, dated July 8, 2020, by and between the Company and Lincoln Park Capital Fund, LLC
(Filed With SEC on July 14, 2020)
-
Promissory Note
(Filed With SEC on March 31, 2020)
-
Note Purchase Agreement
(Filed With SEC on March 31, 2020)
-
Enochian Biosciences, Inc. 2019 Equity Incentive Plan
(Filed With SEC on February 10, 2020)
-
License Agreement
(Filed With SEC on February 3, 2020)
-
Offer Letter from the Company to Luisa Puche, dated December 28, 2018
(Filed With SEC on September 30, 2019)
-
Consulting Agreement by and between the Company and G-Tech Bio, LLC July 9, 2018
(Filed With SEC on September 30, 2019)
-
Amended and Restated Director Agreement by and between the Company and Mark Dybul, as amended, dated May 1, 2019
(Filed With SEC on September 30, 2019)
-
Lease Agreement dated June 19, 2018
(Filed With SEC on June 25, 2018)
-
Consulting Agreement with Carl Sandler
(Filed With SEC on May 15, 2018)
-
Sublease Agreement
(Filed With SEC on May 15, 2018)
-
Consulting Agreement with Weird Science
(Filed With SEC on May 15, 2018)
-
US Subscription Agreement
(Filed With SEC on February 23, 2018)
-
Non-US Subscription Agreement
(Filed With SEC on February 23, 2018)
-
Form of Grant Warrant
(Filed With SEC on February 9, 2018)
-
RS Consulting Agreement
(Filed With SEC on February 9, 2018)
-
Amendment to CFO Service Agreement
(Filed With SEC on February 9, 2018)
-
Form of Convertible Note Amendment
(Filed With SEC on February 9, 2018)
-
Lease Agreement dated November 13, 2017
(Filed With SEC on November 17, 2017)
-
CFO Service Agreement by and between DanDrit Denmark and Mr. Robert Wolfe effective July 11, 2017
(Filed With SEC on September 29, 2017)
-
Promissory Note dated July 14, 2017
(Filed With SEC on July 20, 2017)
-
Form of Warrant
(Filed With SEC on May 1, 2017)
-
Form of Subscription Agreement
(Filed With SEC on May 1, 2017)
-
SECONDAMENDMENT TO ASSET PURCHASE AGREEMENT
(Filed With SEC on November 10, 2016)
-
ASSET PURCHASE AGREEMENT
(Filed With SEC on April 5, 2016)
-
Page 8
(Filed With SEC on March 18, 2015)
-
SECURITIESPURCHASE AGREEMENT
(Filed With SEC on December 31, 2014)
-
PLACEMENT AGENCY AGREEMENT
(Filed With SEC on August 14, 2014)
-
PLACEMENT AGENCY AGREEMENT
(Filed With SEC on July 3, 2014)
-
PLACEMENT AGENCY AGREEMENT
(Filed With SEC on June 23, 2014)
-
EFS/DVS/NDA20130307CONFIDENTIAL DISCLOSURE AGREEMENT
(Filed With SEC on May 16, 2014)
-
PLACEMENT AGENCY AGREEMENT
(Filed With SEC on May 16, 2014)
-
Lock-Up Agreement
(Filed With SEC on March 31, 2014)
-
Consulting Agreement
(Filed With SEC on March 31, 2014)
-
DANDRIT BIOTECH USA, INC. 2014 EQUITY INCENTIVE PLAN
(Filed With SEC on March 31, 2014)
-
LEASE AGREEMENT
(Filed With SEC on March 31, 2014)
-
Law Firm P/SN. E. NielsenLawyerOur ref 284756-GGI
(Filed With SEC on March 31, 2014)
-
LawFirmPISN.E.NielsenOurref:284756-GGI
(Filed With SEC on February 14, 2014)
-
AGREEMENT AND PLAN OF SHARE EXCHANGE
(Filed With SEC on February 14, 2014)
-
DANDRIT BIOTECH USA, INC. 2014 EQUITY INCENTIVE PLAN
(Filed With SEC on February 14, 2014)
-
Consulting Agreement
(Filed With SEC on February 14, 2014)
-
SHARE CANCELLATION AGREEMENT
(Filed With SEC on February 14, 2014)
-
EARLY ACCESS AGREEMENT
(Filed With SEC on February 14, 2014)
-
LOAN AGREEMENT
(Filed With SEC on February 14, 2014)
-
On the date hereof, Ordnung ApS Danish CVR no. 3351 0950 (hereinafter referred to as Ordnung) and DanDrit Biotech A/S c/o Dina Rosenberg Danish CVR No/SE No 2602 7322 (hereinafter...
(Filed With SEC on February 14, 2014)
-
F I X E D - T E R M L E A S E A G R E E M E N T CONCERNING B A S E M E N T R O O M Between Symbion A/S Danish (CVR) No 10 36 97 03 Fruebjergvej 3, DK-2100 Copenhagen ( hereinafter...
(Filed With SEC on February 14, 2014)
-
1SUBJECT-MATTER
(Filed With SEC on February 14, 2014)
-
Lett Law FirmAdvokat Sren BrinkmannJ.no. 271930-LKP
(Filed With SEC on February 14, 2014)
-
MASTER SERVICES AGREEMENT
(Filed With SEC on February 14, 2014)
-
Colla boration Agreement
(Filed With SEC on February 14, 2014)
-
Alexei Kirkin Strandboulevarden 61,2nd floor to the left DK-2100Copenhagen
(Filed With SEC on February 14, 2014)